Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Boehringer Ingelheim (United States)
InstitutionResearch output, impact & collaborations
Boehringer Ingelheim (United States) is a research organisation in Ridgefield, US. OpenAlex records 6,479 works and 785,366 citations for it. 1,672 researchers list it as their most recent affiliation.
6,479
Works
785,366
Citations
1,672
Researchers
26.2
Avg h-index
How has Boehringer Ingelheim (United States)'s publication output changed over time?
ScholarIQpublication output · 2008–2017
Output grew0% over the shown period — from 1 works in 2008 to 1 in 2017.
1
1
1
1
3
2
2
1
20082009201020132014201520162017
Who are the most-cited researchers behind Boehringer Ingelheim (United States)?
ScholarIQtop researchers by citations
What are the most-cited papers on Boehringer Ingelheim (United States)?
ScholarIQmost cited works
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Bernard Zinman, Christoph Wanner, John M. Lachin, David Fitchett, Erich Bluhmki, Stefan Hantel, Michaela Mattheus, Theresa Devins, Odd Erik Johansen, Hans J. Woerle, Uli C. Broedl, Silvio E. Inzucchi
New England Journal of Medicine. 201512,121 CitationsOPEN ACCESS
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
Christoph Wanner, Silvio E. Inzucchi, John M. Lachin, David Fitchett, Maximilian von Eynatten, Michaela Mattheus, Odd Erik Johansen, Hans J. Woerle, Uli C. Broedl, Bernard Zinman
New England Journal of Medicine. 20163,655 CitationsOPEN ACCESS
Renal Hemodynamic Effect of Sodium-Glucose Cotransporter 2 Inhibition in Patients With Type 1 Diabetes Mellitus
David Z.I. Cherney, Bruce A. Perkins, Nima Soleymanlou, M Maione, Vesta Lai, Alana Lee, Nora Fagan, Hans J. Woerle, Odd Erik Johansen, Uli C. Broedl, Maximilian von Eynatten
Circulation. 20131,319 CitationsOPEN ACCESS
Metabolic response to sodium-glucose cotransporter 2 inhibition in type 2 diabetic patients
Ele Ferrannini, Elza Muscelli, Silvia Frascerra, Simona Baldi, Andrea Mari, Tim Heise, Uli C. Broedl, Hans‐Juergen Woerle
S114430552. 20141,137 CitationsOPEN ACCESS
Heart failure outcomes with empagliflozin in patients with type 2 diabetes at high cardiovascular risk: results of the EMPA-REG OUTCOME <sup>®</sup> trial
David Fitchett, Bernard Zinman, Christoph Wanner, John M. Lachin, Stefan Hantel, Afshin Salsali, Odd Erik Johansen, Hans J. Woerle, Uli C. Broedl, Silvio E. Inzucchi
European Heart Journal. 2016906 CitationsOPEN ACCESS
How much of the research on Boehringer Ingelheim (United States) is open access?
ScholarIQopen access share
92%OPEN ACCESS
Gold
17%
Green
17%
Hybrid
17%
Bronze
42%
Closed
8%
Related on ScholarIQ
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Top Topic
Chronic Obstructive Pulmonary Disease (COPD) Research
Top Topic
Diabetes Treatment and Management
Top Topic
Computational Drug Discovery Methods
Top Topic
Lung Cancer Treatments and Mutations
Top Topic
Atrial Fibrillation Management and Outcomes
Top Topic